Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (right eye)
ICD-10 E10.3521 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (right eye).
E10.3521 refers to a specific condition in patients with Type 1 diabetes mellitus characterized by proliferative diabetic retinopathy (PDR) that has progressed to include traction retinal detachment affecting the macula of the right eye. PDR is a severe form of diabetic retinopathy where new, abnormal blood vessels grow on the retina, which can lead to vision loss. The presence of traction retinal detachment indicates that these abnormal vessels are pulling on the retina, potentially causing it to detach from the underlying tissue. This condition is often associated with poor glycemic control, indicated by elevated HbA1c levels, which reflect chronic hyperglycemia. Management typically involves insulin therapy to maintain blood glucose levels within target ranges, alongside regular ophthalmologic evaluations to monitor retinal health. Early intervention is crucial to prevent irreversible vision loss, and treatment options may include laser photocoagulation or vitrectomy, depending on the severity of the detachment.
Detailed records of diabetes management, including insulin regimens and HbA1c levels.
Patients with poorly controlled Type 1 diabetes presenting with complications.
Ensure comprehensive documentation of diabetes management and any referrals to ophthalmology.
Thorough documentation of retinal examinations, imaging results, and treatment plans.
Patients with diabetic retinopathy requiring laser treatment or surgical intervention.
Document the specific eye affected and the nature of the retinal detachment.
Used for treatment of proliferative diabetic retinopathy.
Document the indication for laser treatment and the extent of the procedure.
Ophthalmologists should ensure that the diagnosis aligns with the procedure performed.
Specifying the eye affected is crucial for treatment planning and monitoring, as it directly impacts the management of the patient's vision and the type of interventions required.
